These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38097497)

  • 41. Bariatric Surgery and Weight Gain: Bibliometric Analysis.
    Seckin D; Cebeci F
    Obes Surg; 2024 Mar; 34(3):929-939. PubMed ID: 38228946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management.
    Geerts A; Lefere S
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S276-S285. PubMed ID: 36545709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Asia's Growing Contribution to Obesity Surgery Research: A 40-year Bibliometric Analysis.
    Liu Z; Wang H; Fan D; Xu T; Wan F; Xia Q
    Obes Surg; 2024 Jun; 34(6):2139-2153. PubMed ID: 38448708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet.
    Schwenger KJP; Fischer SE; Jackson TD; Okrainec A; Allard JP
    Obes Surg; 2018 Apr; 28(4):1109-1116. PubMed ID: 29098545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis.
    Navarro-Masip È; Mestres N; Zorzano-Martínez M; Salinas-Roca B; Sánchez E; López-Cano C; Herrerías F; de la Fuente MC; Santamaría M; León-Mengíbar J; Soler AG; Bueno M; Lecube A
    Obes Surg; 2024 Mar; 34(3):841-849. PubMed ID: 38285299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paediatric gastroenterology. On a knife-edge--weight-loss surgery for NAFLD in adolescents.
    Xanthakos SA; Schwimmer JB
    Nat Rev Gastroenterol Hepatol; 2015 Jun; 12(6):316-8. PubMed ID: 25869913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study.
    Toman D; Vavra P; Jelinek P; Ostruszka P; Ihnat P; Foltys A; Pelikan A; Roman J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):195-203. PubMed ID: 33885048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reply to "Crashing NASH in Patients Listed for Bariatric Surgery".
    Ooi GJ; Burton PR; Kemp WW; Roberts SK; Brown WA
    Obes Surg; 2019 Feb; 29(2):640-641. PubMed ID: 30565101
    [No Abstract]   [Full Text] [Related]  

  • 49. The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease.
    Nostedt JJ; Switzer NJ; Gill RS; Dang J; Birch DW; de Gara C; Bailey RJ; Karmali S
    Can J Gastroenterol Hepatol; 2016; 2016():2059245. PubMed ID: 27777925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years.
    Goday A; Julià H; de Vargas-Machuca A; Pedro-Botet J; Benavente S; Ramon JM; Pera M; Casajoana A; Villatoro M; Fontané L; Bisbe M; Climent E; Castañer O; Flores Le Roux JA; Benaiges D
    Surg Obes Relat Dis; 2021 Dec; 17(12):2047-2053. PubMed ID: 34509375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.
    Ramos-Molina B; Castellano-Castillo D; Pastor O; Ocaña-Wilhelmi L; Fernández-García D; Romero-Gómez M; Cardona F; Tinahones FJ
    Obes Surg; 2019 Mar; 29(3):983-989. PubMed ID: 30488259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
    Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
    Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?
    Juárez-Hernández E; Velázquez-Alemán AP; Castro-Narro G; Uribe M; López-Méndez I
    Front Endocrinol (Lausanne); 2022; 13():1026444. PubMed ID: 36523596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crashing NASH in Patients Listed for Bariatric Surgery.
    De Munck TJI; Verhaegh PLM; Verbeek J; Verheij J; Greve JW; Jonkers DMAE; Masclee AAM; Koek GH
    Obes Surg; 2019 Mar; 29(3):1012-1014. PubMed ID: 30604081
    [No Abstract]   [Full Text] [Related]  

  • 55. A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery.
    Liu SY; Wong VW; Wong SK; Wong GL; Lai CM; Lam CC; Shu SS; Chan HL; Ng EK
    Sci Rep; 2021 Mar; 11(1):5416. PubMed ID: 33686111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery.
    Tavaglione F; De Vincentis A; Bruni V; Gallo IF; Carotti S; Tuccinardi D; Spagnolo G; Ciociola E; Mancina RM; Jamialahmadi O; D'Alessio R; Bottazzi B; Manfrini S; Picardi A; Perrone G; Pozzilli P; Caricato M; Vespasiani-Gentilucci U; Romeo S
    Liver Int; 2022 Feb; 42(2):374-383. PubMed ID: 34890093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.
    Hedderich DM; Hasenberg T; Haneder S; Schoenberg SO; Kücükoglu Ö; Canbay A; Otto M
    Obes Surg; 2017 Jul; 27(7):1755-1762. PubMed ID: 28064372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery.
    Yuan X; Chen J; Cheng Q; Zhao Y; Zhang P; Shao X; Bi Y; Shi X; Ding Y; Sun X; Xue B
    BMC Gastroenterol; 2018 Oct; 18(1):147. PubMed ID: 30285651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests.
    Netanel C; Goitein D; Rubin M; Kleinbaum Y; Katsherginsky S; Hermon H; Tsaraf K; Tachlytski I; Herman A; Safran M; Ben-Ari Z
    Am J Surg; 2021 Jul; 222(1):214-219. PubMed ID: 33309037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.